Biotech | March 29, 2022
AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
